-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2023 to 2024.
- Neuphoria Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $11.6K.
- Neuphoria Therapeutics Inc. annual Income Tax Expense (Benefit) for 2024 was -$87.3K, a 37.3% increase from 2023.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)